Pathophysiology of Post-COVID syndromes: a new perspective
GES Batiha, HM Al-Kuraishy, AI Al-Gareeb, NN Welson - Virology Journal, 2022 - Springer
Most COVID-19 patients recovered with low mortality; however, some patients experienced
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …
COVID-19 and gastrointestinal disease: implications for the gastroenterologist
Background: COVID-19 was initially considered a respiratory disease but the SARS-CoV-2
virus can lead to serious systemic consequences affecting major organs including the …
virus can lead to serious systemic consequences affecting major organs including the …
[HTML][HTML] Crystal structure of SARS-CoV-2 papain-like protease
X Gao, B Qin, P Chen, K Zhu, P Hou, JA Wojdyla… - … Pharmaceutica Sinica B, 2021 - Elsevier
The pandemic of coronavirus disease 2019 (COVID-19) is changing the world like never
before. This crisis is unlikely contained in the absence of effective therapeutics or vaccine …
before. This crisis is unlikely contained in the absence of effective therapeutics or vaccine …
An aberrant STAT pathway is central to COVID-19
T Matsuyama, SP Kubli, SK Yoshinaga… - Cell Death & …, 2020 - nature.com
COVID-19 is caused by SARS-CoV-2 infection and characterized by diverse clinical
symptoms. Type I interferon (IFN-I) production is impaired and severe cases lead to ARDS …
symptoms. Type I interferon (IFN-I) production is impaired and severe cases lead to ARDS …
[HTML][HTML] Recent advances in management of COVID-19: A review
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …
significant mortality and economic consequences all over the globe. As of today, there are …
Two different antibody-dependent enhancement (ADE) risks for SARS-CoV-2 antibodies
DO Ricke - Frontiers in immunology, 2021 - frontiersin.org
COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-
like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease …
like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease …
Impact of famotidine use on clinical outcomes of hospitalized patients with COVID-19
JF Mather, RL Seip, RG McKay - Official journal of the American …, 2020 - journals.lww.com
METHODS: Retrospective, propensity-matched observational study of consecutive COVID-
19–positive patients between February 24, 2020, and May 13, 2020. RESULTS: Of 878 …
19–positive patients between February 24, 2020, and May 13, 2020. RESULTS: Of 878 …
The relevance of magnesium homeostasis in COVID-19
V Trapani, A Rosanoff, S Baniasadi… - European journal of …, 2022 - Springer
Purpose In less than one and a half year, the COVID-19 pandemic has nearly brought to a
collapse our health care and economic systems. The scientific research community has …
collapse our health care and economic systems. The scientific research community has …
Inhibitors of sars-cov-2 plpro
The emergence of SARS-CoV-2 causing the COVID-19 pandemic, has highlighted how a
combination of urgency, collaboration and building on existing research can enable rapid …
combination of urgency, collaboration and building on existing research can enable rapid …
[HTML][HTML] Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the
first documented pandemic due to a coronavirus that continues to be a major health …
first documented pandemic due to a coronavirus that continues to be a major health …